Olfactory dysfunction is a common sensory disorder, but there are currently no standard diagnostics or therapeuticmethods. We analyzed the effects of systemic steroidtherapy in patients with olfactory dysfunction. MATERIALS AND
METHOD:
We analyzed patientswho visited our ENT department with olfactory dysfunction for 3 years. We reviewed their charts and classified the patients according to age, sex, etiology of olfactory dysfunction, degrees of olfactory dysfunction and the effect of systemic steroidtherapy.
RESULTS:
The mean age was 44.3 years old and there were 50 males and 55 females; 55 patients had inflammatory disease and 50 patients had non-inflammatory disease. The distribution of degrees of olfactory disorder according to cause was not significantly different (p=0.120). In 105 patients, 20% experienced improvements after systemic steroidtherapy, and the response of systemic steroidtherapy was better among patients with inflammatory causes. In cases of inflammatory disease, there was a larger amount of severe hyposmiapatients, and their response to systemic steroidtherapy was significant (p=0.015). Patients with mild and moderate hyposmia were more responsive to systemic steroidtherapy than patients with severe hyposmia (p=0.382).